版本:
中国

BRIEF-Histogenics posts Q1 loss per share $0.27

May 11 Histogenics Corp

* Histogenics Corporation announces first quarter 2017 financial and operating results

* Q1 loss per share $0.27

* Q1 earnings per share view $-0.35 -- Thomson Reuters I/B/E/S

* Histogenics Corp - neocart approval pathway in japan defined after successful conclusion of discussions with Japan Pharmaceuticals and Medical Devices Agency

* Histogenics Corp - as of March 31, 2017, had cash, cash equivalents and marketable securities of $24.4 million, compared to $31.9 million at December 31, 2016 Source text for Eikon: Further company coverage:

我们的标准: 汤森路透“信任原则

更多 公司新闻(英文)

热门文章

编辑推荐

文章推荐